![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 12254 |
FusionGeneSummary for EXOC1_IDO1 |
![]() |
Fusion gene information | Fusion gene name: EXOC1_IDO1 | Fusion gene ID: 12254 | Hgene | Tgene | Gene symbol | EXOC1 | IDO1 | Gene ID | 55763 | 3620 |
Gene name | exocyst complex component 1 | indoleamine 2,3-dioxygenase 1 | |
Synonyms | BM-102|SEC3|SEC3L1|SEC3P | IDO|IDO-1|INDO | |
Cytomap | 4q12 | 8p11.21 | |
Type of gene | protein-coding | protein-coding | |
Description | exocyst complex component 1SEC3-like 1exocyst complex component Sec3 | indoleamine 2,3-dioxygenase 1indolamine 2,3 dioxygenaseindole 2,3-dioxygenaseindoleamine-pyrrole 2,3-dioxygenase | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q9NV70 | P14902 | |
Ensembl transtripts involved in fusion gene | ENST00000381295, ENST00000346134, ENST00000349598, | ENST00000522495, ENST00000518237, | |
Fusion gene scores | * DoF score | 4 X 3 X 4=48 | 4 X 4 X 4=64 |
# samples | 4 | 4 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EXOC1 [Title/Abstract] AND IDO1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EXOC1 | GO:0048015 | phosphatidylinositol-mediated signaling | 25591774 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LUAD | TCGA-97-8179-01A | EXOC1 | chr4 | 56768704 | + | IDO1 | chr8 | 39780071 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000381295 | ENST00000522495 | EXOC1 | chr4 | 56768704 | + | IDO1 | chr8 | 39780071 | + |
Frame-shift | ENST00000381295 | ENST00000518237 | EXOC1 | chr4 | 56768704 | + | IDO1 | chr8 | 39780071 | + |
Frame-shift | ENST00000346134 | ENST00000522495 | EXOC1 | chr4 | 56768704 | + | IDO1 | chr8 | 39780071 | + |
Frame-shift | ENST00000346134 | ENST00000518237 | EXOC1 | chr4 | 56768704 | + | IDO1 | chr8 | 39780071 | + |
Frame-shift | ENST00000349598 | ENST00000522495 | EXOC1 | chr4 | 56768704 | + | IDO1 | chr8 | 39780071 | + |
Frame-shift | ENST00000349598 | ENST00000518237 | EXOC1 | chr4 | 56768704 | + | IDO1 | chr8 | 39780071 | + |
Top |
FusionProtFeatures for EXOC1_IDO1 |
![]() |
Hgene | Tgene |
EXOC1 | IDO1 |
Component of the exocyst complex involved in the dockingof exocytic vesicles with fusion sites on the plasma membrane. (Microbial infection) Has an antiviral effect againstflaviviruses by affecting viral RNA transcription and translationthrough the sequestration of elongation factor 1-alpha (EEF1A1).This results in decreased viral RNA synthesis and decreased viralprotein translation. {ECO:0000269|PubMed:19889084}. | Catalyzes the first and rate limiting step of thecatabolism of the essential amino acid tryptophan along thekynurenine pathway (PubMed:17671174). Involved in the peripheralimmune tolerance, contributing to maintain homeostasis bypreventing autoimmunity or immunopathology that would result fromuncontrolled and overreacting immune responses (PubMed:25691885).Tryptophan shortage inhibits T lymphocytes division andaccumulation of tryptophan catabolites induces T-cell apoptosisand differentiation of regulatory T-cells (PubMed:25691885). Actsas a suppressor of anti-tumor immunity (PubMed:23103127,PubMed:25157255, PubMed:14502282, PubMed:25691885). Limits thegrowth of intracellular pathogens by depriving tryptophan(PubMed:25691885). Protects the fetus from maternal immunerejection (PubMed:25691885). {ECO:0000269|PubMed:14502282,ECO:0000269|PubMed:17671174, ECO:0000303|PubMed:23103127,ECO:0000303|PubMed:25157255, ECO:0000303|PubMed:25691885}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for EXOC1_IDO1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for EXOC1_IDO1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
EXOC1 | CDC5L, DISC1, TRAF3IP1, TRIO, DST, LUC7L2, EXOC4, SYBU, SPTAN1, SFR1, CCSER2, CCDC93, CCDC88A, KDM1A, NUF2, MACF1, SRGAP2, GOLGA4, SH3BP5, CEP295, KIAA1551, KIF5A, TRIM9, KANSL1, COLEC12, IQCB1, KIAA0226, RB1CC1, ATG14, SNAP29, BSG, CD274, THAP7, KIR2DS2, CA14, DTNBP1, TMEFF1, SCN2B, EXOC2, EXOC3, NTRK1, MED4, SNW1, EXOC6, NCKAP5L, TUFT1, GRIPAP1, CLOCK, FKBP15, PTRF, BLOC1S4, IKBIP, RABEP2, RABGAP1L, NDC80, PHF21A, IL1R2, EXOC6B, EXOC8, VPS53, RABGEF1, CCDC6, CCDC132, TRIM32, EXOC5, KXD1, GIT2, POTEE, ARHGEF7, SNAPIN, VPS51, BLOC1S2, EXOC7, USP4, THAP11, TSKS, JUN, TSSC1, TNFRSF8, CCHCR1, SIKE1, GIT1, KIF5B, RABEP1, NUP54, TNIP1, GOLGA5, COG6, KIF5C, STRN3, STRN, APLNR, PCNT, CCDC122, EDNRB, ZWINT, VTI1B, TMED1, RALB, MTNR1A | IDO1 | PPP1R16A, TERF2IP, APP |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for EXOC1_IDO1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | IDO1 | P14902 | DB00435 | Nitric Oxide | Indoleamine 2,3-dioxygenase 1 | small molecule | approved |
Top |
RelatedDiseases for EXOC1_IDO1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | IDO1 | C0011570 | Mental Depression | 4 | PSYGENET |
Tgene | IDO1 | C0011581 | Depressive disorder | 4 | PSYGENET |
Tgene | IDO1 | C0014175 | Endometriosis | 1 | CTD_human |
Tgene | IDO1 | C0021368 | Inflammation | 1 | CTD_human |
Tgene | IDO1 | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
Tgene | IDO1 | C0028754 | Obesity | 1 | CTD_human |
Tgene | IDO1 | C0043094 | Weight Gain | 1 | CTD_human |
Tgene | IDO1 | C0178417 | Anhedonia | 1 | PSYGENET |
Tgene | IDO1 | C0338715 | Drug-induced depressive state | 1 | PSYGENET |
Tgene | IDO1 | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
Tgene | IDO1 | C0581391 | Chronic depression | 1 | PSYGENET |
Tgene | IDO1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |